Inventor
KWAKKENBOS MARK JEROEN
NL16 patents
⚠️ This page may combine multiple inventors who share the name “KWAKKENBOS MARK JEROEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
6 patentsUS9458228B2Oct 4, 2016
Gram-positive bacteria specific binding compounds
GENENTECH INC3 citations83
US9399673B2Jul 26, 2016
Gram-positive bacteria specific binding compounds
GENENTECH INC7 citations83
US9266943B2Feb 23, 2016
Gram-positive bacteria specific binding compounds
GENENTECH INC3 citations83
US9090677B2Jul 28, 2015
Gram-positive bacteria specific binding compounds
GENENTECH INC6 citations83
US9927428B2Mar 27, 2018
Gram-positive bacteria specific binding compounds
GENENTECH INC0 citations51
US9688745B2Jun 27, 2017
Gram-positive bacteria specific binding compounds
GENENTECH INC0 citations51
MEDIMMUNE LTD
3 patentsUS10059757B2Aug 28, 2018
RSV-specific binding molecules and means for producing them
MEDIMMUNE LTD8 citations83
US9321831B2Apr 26, 2016
RSV-specific binding molecules and means for producing them
MEDIMMUNE LTD8 citations83
US10730931B2Aug 4, 2020
RSV-specific binding molecules and means for producing them
MEDIMMUNE LTD3 citations72
AIMM THERAPEUTICS BV
3 patentsUS10344076B2Jul 9, 2019
Means and methods for producing high affinity antibodies
AIMM THERAPEUTICS BV0 citations50
US9969795B2May 15, 2018
Means and methods for producing high affinity antibodies
AIMM THERAPEUTICS BV0 citations49
US10611829B2Apr 7, 2020
Means and methods for producing stable antibodies
AIMM THERAPEUTICS BV0 citations37